![Eugene Sun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Eugene Sun served as the Chief Executive Officer & Director at Melinta Subsidiary Corp.
from 2015 to 2017.
He was also the Independent Director at NVN Liquidation, Inc. from 2018 to 2020.
Prior to that, he was the VP-Global Pharmaceutical Clinical Development at Abbott Laboratories from 2000 to 2011 and the Director at TAP Pharmaceutical Products, Inc. in 2008.
Dr. Sun received his undergraduate degree from Harvard University and his doctorate from New York University School of Medicine.
Precedenti posizioni note di Eugene Sun
| Società | Posizione | Fine |
|---|---|---|
| NVN LIQUIDATION, INC. | Direttore/Membro del Consiglio | 29/01/2020 |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Amministratore Delegato | 01/01/2017 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 24/08/2012 |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets pharmaceutical products | Direttore/Membro del Consiglio | 01/01/2008 |
Formazione di Eugene Sun
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
77
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets pharmaceutical products | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
